tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Emergent BioSolutions announces new contract modification for ACAM2000
PremiumThe FlyEmergent BioSolutions announces new contract modification for ACAM2000
18d ago
Emergent BioSolutions Advances Pediatric Botulism Antitoxin Study
Premium
Company Announcements
Emergent BioSolutions Advances Pediatric Botulism Antitoxin Study
20d ago
Emergent BioSolutions Secures $30M BARDA Contract Extension
Premium
Company Announcements
Emergent BioSolutions Secures $30M BARDA Contract Extension
22d ago
Emergent BioSolutions partners with Voices for Awareness, Facing Fentanyl Now
PremiumThe FlyEmergent BioSolutions partners with Voices for Awareness, Facing Fentanyl Now
1M ago
Emergent BioSolutions’ AIGIV Study: A Potential Game-Changer in Anthrax Treatment
Premium
Company Announcements
Emergent BioSolutions’ AIGIV Study: A Potential Game-Changer in Anthrax Treatment
1M ago
Emergent BioSolutions’ AIGIV Study: A Key Development in Anthrax Treatment
Premium
Company Announcements
Emergent BioSolutions’ AIGIV Study: A Key Development in Anthrax Treatment
1M ago
Emergent BioSolutions reports Q2 adjusted EPS 16c vs ($2.32) last year
PremiumThe FlyEmergent BioSolutions reports Q2 adjusted EPS 16c vs ($2.32) last year
2M ago
Emergent BioSolutions narrows FY25 revenue to $765M-$835M from $750M-$850M
Premium
The Fly
Emergent BioSolutions narrows FY25 revenue to $765M-$835M from $750M-$850M
2M ago
Emergent BioSolutions sees Q3 revenue $180M-$210M, consensus $212.7M
Premium
The Fly
Emergent BioSolutions sees Q3 revenue $180M-$210M, consensus $212.7M
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100